Commit Biologics raises €54M seed to advance cancer and autoimmune therapies
EU-Startups· David Cendon Garcia·· 17 hours agoTop DealsAI Score69
Commit Biologics raises €54M seed to advance cancer and autoimmune therapies
Denmark’s Commit Biologics secures €54 million Seed funding to advance cancer and autoimmune therapies
AI Overview
Copenhagen-based Commit Biologics raised €54 million ($60 million) in seed funding led by Ackermans & van Haaren.
Why it matters
Commit Biologics' €54M seed round shows investors backing a complement-based immunotherapy platform that works without T cells, a contrast to the T cell engagers and cell therapies that dominate the field.